Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials

被引：93

作者：

Leach, MO ^{[1
]}

Brindle, KM ^{[1
]}

Evelhoch, JL ^{[1
]}

Griffiths, JR ^{[1
]}

Horsman, MR ^{[1
]}

Jackson, A ^{[1
]}

Jayson, G ^{[1
]}

Judson, IR ^{[1
]}

Knopp, MV ^{[1
]}

Maxwell, RJ ^{[1
]}

McIntyre, D ^{[1
]}

Padhani, AR ^{[1
]}

Price, P ^{[1
]}

Rathbone, R ^{[1
]}

Rustin, G ^{[1
]}

Tofts, PS ^{[1
]}

Tozer, GM ^{[1
]}

Vennart, W ^{[1
]}

Waterton, JC ^{[1
]}

Williams, SR ^{[1
]}

Workman, P ^{[1
]}

机构：

[1] Canc Res UK, Drug Dev Off, Pharmacodynam Pharmacokinet Technol Advisory Comm, PTAC, London, England

来源：

BRITISH JOURNAL OF RADIOLOGY | 2003年 / 76卷

关键词：

D O I：

10.1259/bjr/15917261

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

[No abstract available]

引用

页码：S87 / S91

页数：5

共 12 条

[1]

Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO

[2]

2-9

[3] Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging [J].

Galbraith, SM ;

Maxwell, RJ ;

Lodge, MA ;

Tozer, GM ;

Wilson, J ;

Taylor, NJ ;

Stirling, JJ ;

Sena, L ;

Padhani, AR ;

Rustin, GJS .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2831-2842

[4] Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging [J].

Galbraith, SM ;

Rustin, GJS ;

Lodge, MA ;

Taylor, NJ ;

Stirling, JJ ;

Jameson, M ;

Thompson, P ;

Hough, D ;

Gumbrell, L ;

Padhani, AR .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3826-3840

[5] Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme [J].

Gossmann, A ;

Helbich, TH ;

Kuriyama, N ;

Ostrowitzki, S ;

Roberts, TPL ;

Shames, DM ;

van Bruggen, N ;

Wendland, MF ;

Israel, MA ;

Brasch, RC .

JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 15 (03) :233-240

[6] Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: Implications for trial design of antiangiogenic antibodies [J].

Jayson, GC ;

Zweit, J ;

Jackson, A ;

Mulatero, C ;

Julyan, P ;

Ranson, M ;

Broughton, L ;

Wagstaff, J ;

Hakannson, L ;

Groenewegen, G ;

Bailey, J ;

Smith, N ;

Hastings, D ;

Lawrance, J ;

Haroon, H ;

Ward, T ;

McGown, AT ;

Tang, M ;

Levitt, D ;

Marreaud, S ;

Lehmann, FF ;

Herold, M ;

Zwierzina, H .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (19) :1484-1493

[7]

LEACH MO, 2003, P INT SOC MAGN RES M, P1268

[8]

LEACH MO, 2003, P 94 ANN M AM ASS CA, P504

[9] Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases:: Results from two phase I studies [J].

Morgan, B ;

Thomas, AL ;

Drevs, J ;

Hennig, J ;

Buchert, M ;

Jivan, A ;

Horsfield, MA ;

Mross, K ;

Ball, HA ;

Lee, L ;

Mietlowski, W ;

Fuxius, S ;

Unger, C ;

O'Byrne, K ;

Henry, A ;

Cherryman, GR ;

Laurent, D ;

Dugan, M ;

Marmé, D ;

Steward, WP .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :3955-3964

[10]

Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO

← 1 2 →